CT纹理分析评估可切除与交界可切除胰腺导管腺癌新辅助治疗反应
前瞻性研究纳入39例接受新辅助化疗并手术切除的胰腺导管腺癌患者,用CT胰腺期纹理特征预测组织学与生化反应及无病生存。治疗前细/中级别滤波平均阳性像素及中级别滤波峰度等参数在组织学反应组间有差异,基线平均阳性像素较高者更可能获得良好组织学反应(OR 1.06,95%CI 1.002-1.12),纹理特征与无病生存相关(P=0.001)。
要点
- 治疗前CT胰腺期纹理特征可预测胰腺导管腺癌新辅助化疗后的组织学反应。
- 纹理特征纵向变化与生化反应及无病生存相关,可作为潜在生物标志物。
- 基线平均阳性像素较高者更可能获得良好组织学反应(OR 1.06,95%CI 1.002-1.12)。
核心结论
- 基线胰腺期CT纹理特征及肿瘤异质性纵向变化可作为预测新辅助化疗组织学反应和无病生存的生物标志物。
研究设计与样本
- 前瞻性研究,39例可切除或交界可切除胰腺导管腺癌患者于2013年11月至2016年12月完成研究方案。
- 所有患者接受新辅助化疗和手术切除,并进行组织学分级评估肿瘤反应,全部使用相似CT协议。
- 评估治疗前后CT胰腺期(晚动脉期)图像,采用直方图分析和空间带通滤波提取纹理特征。
诊断标准与关键数值
- 无或差组织学反应与良好组织学反应组间,治疗前细/中级别滤波平均阳性像素、治疗前中级别滤波峰度、峰度变化及治疗前肿瘤标准差差异有统计学意义(p<0.05)。
- 中级别滤波偏度和峰度变化与生化反应显著相关(p<0.01)。
- 多因素分析显示治疗前CT平均阳性像素较高者更可能获得良好组织学反应(OR 1.06,95%CI 1.002-1.12)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The goal of this study was to assess the correlation between CT-derived texture features of pancreatic ductal adenocarcinoma (PDAC) and histologic and biochemical markers of response to neoadjuvant treatment as well as disease-free survival in patients with potentially resectable PDAC. SUBJECTS AND METHODS. Thirty-nine patients completed this prospective study protocol between November 2013 and December 2016. All patients received neoadjuvant chemotherapy, underwent surgical resection, and had histologic grading of tumor response. Similar CT protocol was used for all patients. Pancreatic (late arterial) phase of pre- and posttreatment CT scans were evaluated. Histogram analysis and spatial-band-pass filtration were used to extract textural features. Correlation between textural parameters, histologic response, biochemical response, and genetic mutations was assessed using Mann-Whitney test, chi-square analysis, and multivariate logistic regression. Association with disease-free survival was assessed using Kaplan-Meier method and Cox model. RESULTS. Pretreatment mean positive pixel (MPP) at fine- and medium-level filtration, pretreatment kurtosis at medium-level filtration, changes in kurtosis, and pretreatment tumor SD were statistically different between patients with no or poor histologic response and favorable histologic response (p < 0.05). Changes in skewness and kurtosis at medium-level filtration significantly correlated with biochemical response (p < 0.01). On the basis of multivariate analysis, patients with higher MPP at pretreatment CT were more likely to have favorable histologic response (odds ratio, 1.06; 95% CI, 1.002-1.12). The Cox model for association between textural features and disease-free survival was statistically significant (p = 0.001). CONCLUSION. Textural features extracted from baseline pancreatic phase CT imaging of patients with potentially resectable PDAC and longitudinal changes in tumor heterogeneity can be used as biomarkers for predicting histologic response to neoadjuvant chemotherapy and disease-free survival.
引用
- Borhani AA, Dewan R, Furlan A, et al. Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma. AJR Am J Roentgenol. 2019. PMID: 31799875. doi:10.2214/AJR.19.21152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。